V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis.
Mirjam J.G. van Manen,Surinder S. Birring,Carlo Vancheri,Virginia Vindigni,Elisabetta A. Renzoni,Anne-Marie Russell,Monique Wapenaar,Vincent Cottin,Marlies S. Wijsenbeek +8 more
TL;DR: This data indicates that in patients with IPF, pirfenidone reduces objective 24-h cough counts and improves subjective measures of cough and quality of life (QoL) measures.
Journal ArticleDOI
Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
Toby M. Maher,Toby M. Maher,Susanne Stowasser,Yasuhiko Nishioka,Eric S. White,Vincent Cottin,Imre Noth,Moisés Selman,Klaus B Rohr,Andreas Michael,Carina Ittrich,Claudia Diefenbach,R. Gisli Jenkins,Tamera Corte,Ian Glaspole,Mark Holmes,Lauren K. Troy,Elizabeth Veitch,Benjamin Bondue,Caroline Dahlqvist,Renaud Louis,Jan Van Meerbeeck,Wim Wuyts,Radka Bittenglova,Vitezslav Kolek,Norbert Pauk,Pavel Reiterer,Martina Sterclova,Maritta Kilpeläinen,Riitta Mäkitaro,Marjukka Myllärniemi,Minna Purokivi,Terhi Rantala,Francis Couturaud,Dominique Israel-Biet,Stéphane Jouneau,Romain Kessler,François Lebargy,Sylvain Marchand-Adam,Tom Bollmann,Andreas Günther,P Hammerl,Joachim Kirschner,Anne-Marie Kirsten,Michael Kreuter,Claus Neurohr,Antje Prasse,Nicolas Schönfeld,Rainer Wiewrodt,Somfay Attila,Medgyasszay Balazs,Eszter Csánky,György Losonczy,Hiroki Hayashi,Sakae Homma,Yoshikazu Inoue,Shinyu Izumi,Hideya Kitamura,Osamu Nishiyama,Takashi Ogura,Masaki Okamoto,Takefumi Saito,Hiroyuki Taniguchi,Yoshiaki Zaizen,Marzena Filipowska,Agnieszka Jarzemska,Wladyslaw Pierzchala,Wojciech Piotrowski,Krzysztof Sladek,Ewa Trawinska,Young Whan Kim,Jong Sun Park,Jin Woo Song,Myriam Aburto,Diego Castillo Villegas,José María Echave-Sustaeta,Christian Garcia Fadul,Susana Herrera,Jorge Moisés,Maria Molina-Molina,Amalia Moreno,Asunción Nieto,María Jesús Rodríguez Nieto,José Antonio Rodríguez-Portal,Belen Safont,Jacobo Sellares,Claudia Valenzuela,Huzaifa Adamali,Nazia Chaudhuri,Michael A Gibbons,Rachel K. Hoyles,Toby Maher,Helen Parfrey,Francis Averill,Steven Chambers,Neil Ettinger,Glenn Giessel,Lisa M Jones,Mitchell Kaye,David Oelberg,Jan H Westerman,Donald Zoz +101 more
TL;DR: The results suggest that change in CRPM is not a marker of response to nintedanib in patients with idiopathic pulmonary fibrosis, and rising concentrations of CRPM over 12 weeks were associated with disease progression.
Journal ArticleDOI
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
Jason Weatherald,Athénaïs Boucly,David Launay,Vincent Cottin,Grégoire Prévot,Delphine Bourlier,Claire Dauphin,Ari Chaouat,Laurent Savale,Laurent Savale,Xavier Jaïs,Xavier Jaïs,Mitja Jevnikar,Mitja Jevnikar,Julie Traclet,Pascal de Groote,Gérald Simonneau,Gérald Simonneau,Eric Hachulla,Luc Mouthon,David Montani,David Montani,Marc Humbert,Olivier Sitbon +23 more
TL;DR: The 6MWD, functional class, cardiac index, SVI, pulmonary arterial compliance and pulmonary vascular resistance were independently associated with transplant-free survival at follow-up, with SVI performing better than other haemodynamic variables.
Journal ArticleDOI
Syndrome emphysème des sommets et fibrose pulmonaire des bases combinés (syndrome emphysème/fibrose) : aspects tomodensitométriques et fonctionnels
Pierre-Yves Brillet,Vincent Cottin,P. Letoumelin,F. Landino,Michel Brauner,Dominique Valeyre,Jean-François Cordier,Hilario Nunes +7 more
TL;DR: The emphysema/fibrosis syndrome may be associated with different patterns on HRCT corresponding to Specific profiles on pulmonary function tests corresponding to specific profiles on lung function tests.
Journal ArticleDOI
Lung cancer in combined pulmonary fibrosis and emphysema: A series of 47 western patients
Nicolas Girard,Sylvain Marchand-Adam,Jean-Marc Naccache,Raphael Borie,Thierry Urban,Stéphane Jouneau,Eric Marchand,Anne-Claire Ravel,L. Kiakouama,Bénédicte Etienne-Mastroianni,Jacques Cadranel,Vincent Cottin,Jean-François Cordier +12 more
TL;DR: Lung cancer in patients with CPFE syndrome represents a specific entity with a poor prognosis, that further represents the most characteristic and severe model of tobacco-related disease.